ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 92 filers reported holding ODONATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,000 | 0.0% | 2,000 | +150.0% | 0.00% | – |
| Q1 2021 | $3,000 | -99.9% | 800 | -98.9% | 0.00% | – |
| Q2 2020 | $2,981,000 | -30.2% | 70,416 | -54.5% | 0.00% | -100.0% |
| Q1 2020 | $4,269,000 | -14.9% | 154,616 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,018,000 | -27.1% | 154,616 | -41.5% | 0.00% | 0.0% |
| Q3 2019 | $6,886,000 | -52.9% | 264,516 | -33.6% | 0.00% | -50.0% |
| Q2 2019 | $14,625,000 | +58.1% | 398,626 | -4.7% | 0.00% | +100.0% |
| Q1 2019 | $9,248,000 | +54.1% | 418,294 | -1.9% | 0.00% | 0.0% |
| Q4 2018 | $6,002,000 | -38.8% | 426,294 | -15.6% | 0.00% | 0.0% |
| Q3 2018 | $9,800,000 | -47.8% | 504,894 | -40.6% | 0.00% | -50.0% |
| Q2 2018 | $18,768,000 | +4.2% | 850,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $18,003,000 | -15.3% | 850,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $21,250,000 | – | 850,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 14,075,269 | $595,947,000 | 57.94% |
| Samsara BioCapital, LLC | 496,505 | $21,022,000 | 6.76% |
| Boxer Capital, LLC | 3,363,377 | $142,405,000 | 6.26% |
| Opaleye Management Inc. | 250,000 | $10,585,000 | 2.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 785,913 | $33,276,000 | 0.81% |
| RTW INVESTMENTS, LP | 481,027 | $20,367,000 | 0.57% |
| Birchview Capital, LP | 20,000 | $847,000 | 0.51% |
| Rock Springs Capital Management LP | 437,231 | $18,512,000 | 0.51% |
| Redmile Group, LLC | 633,038 | $26,803,000 | 0.50% |
| SABBY MANAGEMENT, LLC | 40,500 | $1,715,000 | 0.34% |